Proactive Investors - Run By Investors For Investors

Symphony Environmental launches range of medical products incorporating d2p technology

Examination gloves will be the first launch in a planned range of antimicrobial disposable healthcare products
Medical gloves
Symphony is collaborating with Health & Hygiene Ltd and Biomax Rubber Industries

Symphony Environmental Technologies plc (LON:SYM) has launched a series of healthcare products, starting with latex examination gloves, made with its antimicrobial d2p technology.

The AIM-listed environmentally friendly plastic maker said it was working with Health & Hygiene Ltd, a British company, and Biomax Rubber Industries of Malaysia through a collaboration agreement signed on 2 February 2018.

WATCH: Symphony Environmental makes significant move into healthcare with new latex gloves

Biomax is one of the fastest growing manufacturers of latex examination gloves in Malaysia and produces more than 1bn gloves per year, certified to ISO-9001 and product certifications of ISO-13485 and CE Marking as Class I Medical Device confirming European conformity and markets its products in over 40 countries.

Malaysia is currently one of the world's largest producers of examination gloves, manufacturing around 230bn units last year. 

The gloves, to be marketed under the newly registered ‘Protector’ brand, will be the first launch in a planned range of antimicrobial disposable healthcare products including face masks, caps, shoe covers, surgeon gowns, lab coats, isolation gowns, bed and pillow covers and hospital waste bags containing d2p technology.

The group says unlike current examination gloves that act as a passive barrier to contamination, the inclusion of the d2p technology means the new gloves will provide an active defence against potentially harmful microbes.

Symphony added that Health & Hygiene Ltd and Biomax are exclusively incorporating the innovative d2p technology, with the Protector gloves offering 99.99% efficacy in accordance with ISO 22196 and ASTM E2180 against commonly occurring organisms including MRSA and Salmonella.

Michael Laurier, Symphony chief executive, said: "We are delighted with the result of the collaboration between ourselves, Biomax and Health & Hygiene Ltd, and excited by the prospect of more products becoming available in the coming months."

In mid-afternoon trading Thursday, Symphony shares were up 9.7% at 25.2p.


--Adds additional information from launch conference and share price-- 


View full SYM profile View Profile

Symphony Environmental Technologies PLC Timeline

Related Articles

April 16 2019
“I think we’re really in a good place at the moment, we’re in a world that wants a solution to plastic pollution,” said chief executive Michael Laurier.

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use